Interactions between metals and α-synuclein -: function or artefact?

被引:44
作者
Brown, David R. [1 ]
机构
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
关键词
amyloid; copper; Lewy body; Parkinson's disease;
D O I
10.1111/j.1742-4658.2007.05917.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-synuclein is one of a family of proteins whose function remains unknown. This protein has become linked to a number of neurodegenerative disease although its potential causative role in these diseases remains mysterious. In diseases such as Parkinson's disease and Lewy body dementias, alpha-synuclein becomes deposited in aggregates termed Lewy bodies. Also, some inherited forms of Parkinson's diseases are linked to mutations in the gene for alpha-synuclein. Studies have mostly focussed on what causes the aggregation of the protein but, like many amyloidogenic proteins associated with a neurodegenerative disorder, this protein has now been suggested to bind copper. This finding is currently controversial. This review examines the evidence that alpha-synuclein is a copper binding protein and discusses whether this has any significance in determining the function of the protein or whether copper binding is at all necessary for aggregation.
引用
收藏
页码:3766 / 3774
页数:9
相关论文
共 80 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Hirai, S ;
Izumiyama, Y ;
Tonozuka-Uehara, H ;
Kawai, M .
BRAIN RESEARCH, 1998, 808 (01) :93-100
[3]   Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease [J].
Barzilai, A ;
Melamed, E .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) :126-132
[4]   The role of α-synuclein in neurodegenerative diseases [J].
Bennett, MC .
PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) :311-331
[5]   Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs [J].
Biere, AL ;
Wood, SJ ;
Wypych, J ;
Steavenson, S ;
Jiang, YJ ;
Anafi, D ;
Jacobsen, FW ;
Jarosinski, MA ;
Wu, GM ;
Louis, JC ;
Martin, F ;
Narhi, LO ;
Citron, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34574-34579
[6]   Interaction of α-synuclein with divalent metal ions reveals key differences:: A link between structure, binding specificity and fibrillation enhancement [J].
Binolfi, Andres ;
Rasia, Rodolfo M. ;
Bertoncini, Carlos W. ;
Ceolin, Marcelo ;
Zweckstetter, Markus ;
Griesinger, Christian ;
Jovin, Thomas M. ;
Fernandez, Claudio O. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (30) :9893-9901
[7]   Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils [J].
Bodles, AM ;
Guthrie, DJS ;
Harriott, P ;
Campbell, P ;
Irvine, GB .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08) :2186-2194
[8]   Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions [J].
Chandra, S ;
Fornai, F ;
Kwon, HB ;
Yazdani, U ;
Atasoy, D ;
Liu, XR ;
Hammer, RE ;
Battaglia, G ;
German, DC ;
Castillo, PE ;
Südhof, TC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14966-14971
[9]   α-synuclein locus duplication as a cause of familial Parkinson's disease [J].
Chartier-Harlin, MC ;
Kachergus, J ;
Roumier, C ;
Mouroux, V ;
Douay, X ;
Lincoln, S ;
Levecque, C ;
Larvor, L ;
Andrieux, J ;
Hulihan, M ;
Waucquier, N ;
Defebvre, L ;
Amouyel, P ;
Farrer, M ;
Destée, A .
LANCET, 2004, 364 (9440) :1167-1169
[10]  
Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO